Gelatin Methacryloyl Based Injectable Cryogels with Tunable Degradability for Cell Delivery

Area of Science:

• Biomaterials Science
• Regenerative Medicine
• Polymer Chemistry

Background:

• Scaffold-based cell delivery enhances cell therapy efficacy by providing a supportive niche for transplanted cells.
• Biomaterial scaffolds improve cell survival, proliferation, and function post-transplantation.
• Current limitations in cell delivery necessitate advanced scaffold designs for improved therapeutic outcomes.

Purpose of the Study:

• To develop injectable gelatin methacryloyl (GelMA) based scaffolds using cryogelation for cell and drug delivery.
• To investigate the tunable degradability and porosity of these cryogels for specific applications.
• To evaluate the cytocompatibility, injectability, and mechanical properties of the developed scaffolds.

Main Methods:

• Synthesis of GelMA-based cryogels incorporating poly(ethylene) glycol (PEG) as a sacrificial polymer.
• Characterization of scaffold porosity (10-142 µm) and tunable degradability (6-10 days).
• In vitro cytocompatibility studies with mammalian cells and rheological analysis for mechanical properties and shape recovery.

Main Results:

• The cryogels exhibited tunable pore sizes suitable for various cell types.
• In vitro studies confirmed excellent cytocompatibility of the scaffolds with mammalian cells.
• The scaffolds demonstrated high injectability with up to 90% cell retention and superior shape recovery after mechanical stress.

Conclusions:

• Injectable GelMA cryogels provide a versatile platform for cell and drug delivery with tunable properties.
• The developed scaffolds offer a minimally invasive alternative to traditional surgical procedures in cell therapy.
• These cryogels hold significant potential for diverse applications in regenerative medicine and tissue engineering.